Enhancer of zeste homolog 2 silencing inhibits tumor growth and lung metastasis in osteosarcoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enhancer of zeste homolog 2 silencing inhibits tumor growth and lung metastasis in osteosarcoma
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-08-12
DOI
10.1038/srep12999
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EZH2 promotes angiogenesis through inhibition of miR-1/Endothelin-1 axis in nasopharyngeal carcinoma
- (2015) Juan Lu et al. Oncotarget
- Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia
- (2014) M. J. Kiel et al. BLOOD
- YC-1 inhibits proliferation of breast cancer cells by down-regulating EZH2 expression via activation of c-Cbl and ERK
- (2014) Ling-Chu Chang et al. BRITISH JOURNAL OF PHARMACOLOGY
- A Positive Feedback Loop between Mesenchymal-like Cancer Cells and Macrophages Is Essential to Breast Cancer Metastasis
- (2014) Shicheng Su et al. CANCER CELL
- Loss of histone demethylase KDM6B enhances aggressiveness of pancreatic cancer through downregulation of C/EBPα
- (2014) Keisuke Yamamoto et al. CARCINOGENESIS
- EZH2 promotes tumor progression by increasing VEGF expression in clear cell renal cell carcinoma
- (2014) Z. Q. Xu et al. Clinical & Translational Oncology
- Role of EZH2 in oral squamous cell carcinoma carcinogenesis
- (2014) Lingbo Zhao et al. GENE
- Classification, imaging, biopsy and staging of osteosarcoma
- (2014) ZileSingh Kundu Indian Journal of Orthopaedics
- Increased EZH2 Expression is Associated With Proliferation and Progression of Cervical Cancer and Indicates a Poor Prognosis
- (2014) Yueyang Liu et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo
- (2014) P W M Ho et al. ONCOGENE
- Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31
- (2014) Q Zhang et al. Cell Death & Disease
- Regulation and Role of EZH2 in Cancer
- (2014) Hirohito Yamaguchi et al. Cancer Research and Treatment
- EZH2-Mediated Inactivation of IFN-γ-JAK-STAT1 Signaling Is an Effective Therapeutic Target in MYC-Driven Prostate Cancer
- (2014) Zhen Ning Wee et al. Cell Reports
- Epigenetic regulation of the pro-apoptosis gene TSSC3 in human osteosarcoma cells
- (2013) Yi Li et al. BIOMEDICINE & PHARMACOTHERAPY
- EZH2 Protein Expression Associates with the Early Pathogenesis, Tumor Progression, and Prognosis of Non-Small Cell Lung Carcinoma
- (2013) C. Behrens et al. CLINICAL CANCER RESEARCH
- Benefits and Adverse Events in Younger Versus Older Patients Receiving Neoadjuvant Chemotherapy for Osteosarcoma: Findings From a Meta-Analysis
- (2013) Marnie Collins et al. JOURNAL OF CLINICAL ONCOLOGY
- TSSC3 overexpression reduces stemness and induces apoptosis of osteosarcoma tumor-initiating cells
- (2012) Yusheng Huang et al. APOPTOSIS
- EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis
- (2012) Francesco Crea et al. CANCER AND METASTASIS REVIEWS
- Polycomb Protein EZH2 Regulates Tumor Invasion via the Transcriptional Repression of the Metastasis Suppressor RKIP in Breast and Prostate Cancer
- (2012) G. Ren et al. CANCER RESEARCH
- EZH2-Regulated DAB2IP Is a Medulloblastoma Tumor Suppressor and a Positive Marker for Survival
- (2012) M. Smits et al. CLINICAL CANCER RESEARCH
- The Maternally Expressed GeneTssc3Regulates the Expression of MASH2 Transcription Factor in Mouse Trophoblast Stem Cells through the AKT-Sp1 Signaling Pathway
- (2012) Tomoka Takao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Intronic RNAs mediate EZH2 regulation of epigenetic targets
- (2012) Sònia Guil et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML
- (2011) J. Zhou et al. BLOOD
- Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications
- (2011) Roberta Ciarapica et al. BMC Medicine
- EZH2 Mediates Epigenetic Silencing of Neuroblastoma Suppressor Genes CASZ1, CLU, RUNX3, and NGFR
- (2011) C. Wang et al. CANCER RESEARCH
- EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes -Catenin-Dependent Hepatocarcinogenesis
- (2011) A. S. L. Cheng et al. CANCER RESEARCH
- Histone Methyltransferase EZH2 Induces Akt-Dependent Genomic Instability and BRCA1 Inhibition in Breast Cancer
- (2011) M. E. Gonzalez et al. CANCER RESEARCH
- TSSC3 overexpression associates with growth inhibition, apoptosis induction and enhances chemotherapeutic effects in human osteosarcoma
- (2011) Huanzi Dai et al. CARCINOGENESIS
- The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2
- (2011) Fang Zheng et al. GUT
- Regulation of Tumor Angiogenesis by EZH2
- (2010) Chunhua Lu et al. CANCER CELL
- The role of EZH2 and DNA methylation in the silencing of the tumour suppressor RUNX3 in colorectal cancer
- (2010) Liudmila L. Kodach et al. CARCINOGENESIS
- EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-β1 and is a predictor of outcome in ovarian carcinoma patients
- (2010) Zhi-Yue Rao et al. CARCINOGENESIS
- The polycomb group gene product Ezh2 regulates proliferation and differentiation of murine hepatic stem/progenitor cells
- (2010) Ryutaro Aoki et al. JOURNAL OF HEPATOLOGY
- PH Domain-Only Protein PHLDA3 Is a p53-Regulated Repressor of Akt
- (2009) Tatsuya Kawase et al. CELL
- High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
- (2009) Li-Ru He et al. INTERNATIONAL JOURNAL OF CANCER
- Inactive Wnt/β-catenin pathway in conventional high-grade osteosarcoma
- (2009) Yongping Cai et al. JOURNAL OF PATHOLOGY
- Epigenetics in cancer: Targeting chromatin modifications
- (2009) L. Ellis et al. MOLECULAR CANCER THERAPEUTICS
- Mir-214-Dependent Regulation of the Polycomb Protein Ezh2 in Skeletal Muscle and Embryonic Stem Cells
- (2009) Aster H. Juan et al. MOLECULAR CELL
- Changes in genomic imprinting and gene expression associated with transformation in a model of human osteosarcoma
- (2008) Yi Li et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Roles of the EZH2 histone methyltransferase in cancer epigenetics
- (2008) Jeffrey A. Simon et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started